丝裂霉素C和亲脂性前药在脂质体和水包油乳剂中经肌肉注射和静脉注射后的血液分布情况。 - Suppr | 超能文献

Blood dispositions of mitomycin C and a lipophilic prodrug after intramuscular and intravenous administration in liposomes and O/W emulsion.

作者信息

Sasaki H, Kakutani T, Hashida M, Kimura T, Sezaki H

出版信息

Chem Pharm Bull (Tokyo). 1985 Jul;33(7):2968-73. doi: 10.1248/cpb.33.2968.

DOI:10.1248/cpb.33.2968

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Blood dispositions of mitomycin C and a lipophilic prodrug after intramuscular and intravenous administration in liposomes and O/W emulsion.丝裂霉素C和亲脂性前药在脂质体和水包油乳剂中经肌肉注射和静脉注射后的血液分布情况。

Chem Pharm Bull (Tokyo). 1985 Jul;33(7):2968-73. doi: 10.1248/cpb.33.2968.

2

Absorption characteristics of the lipophilic prodrug of mitomycin C from injected liposomes or an emulsion.丝裂霉素C亲脂性前药从注射用脂质体或乳剂中的吸收特性。

J Pharm Pharmacol. 1985 Jul;37(7):461-5. doi: 10.1111/j.2042-7158.1985.tb03040.x.

3

Liposomal sustained-release delivery systems for intravenous injection. II. Design of liposome carriers and blood disposition of lipophilic mitomycin C prodrug-bearing liposomes.用于静脉注射的脂质体缓释给药系统。II. 脂质体载体的设计及载有亲脂性丝裂霉素C前药的脂质体的血液处置

Chem Pharm Bull (Tokyo). 1988 Sep;36(9):3557-64. doi: 10.1248/cpb.36.3557.

4

Characterization of liposomes and an emulsion containing mitomycin C or lipophilic mitomycin C prodrugs.含丝裂霉素C或亲脂性丝裂霉素C前药的脂质体和乳剂的特性研究

J Pharm Sci. 1986 Dec;75(12):1166-70. doi: 10.1002/jps.2600751210.

5

Antitumor activity of lipophilic prodrugs of mitomycin C entrapped in liposome or O/W emulsion.

J Pharmacobiodyn. 1984 Feb;7(2):120-30. doi: 10.1248/bpb1978.7.120.

6

Liposomal sustained-release delivery systems for intravenous injection. III. Antitumor activity of lipophilic mitomycin C prodrug-bearing liposomes.用于静脉注射的脂质体缓释给药系统。III. 载亲脂性丝裂霉素C前药脂质体的抗肿瘤活性。

Chem Pharm Bull (Tokyo). 1988 Sep;36(9):3565-73. doi: 10.1248/cpb.36.3565.

7

Release of 5-fluorouracil from intramuscular w/o/w multiple emulsions.5-氟尿嘧啶从肌内注射的复乳（水包油包水型多重乳液）中的释放情况。

Biopharm Drug Dispos. 1989 May-Jun;10(3):257-68. doi: 10.1002/bdd.2510100305.

8

Absorption characteristics of macromolecular prodrugs of mitomycin C following intramuscular administration.丝裂霉素C大分子前药肌肉注射后的吸收特性

Chem Pharm Bull (Tokyo). 1986 Apr;34(4):1775-83. doi: 10.1248/cpb.34.1775.

9

Liposomal sustained-release delivery systems for intravenous injection. I. Physicochemical and biological properties of newly synthesized lipophilic derivatives of mitomycin C.

Chem Pharm Bull (Tokyo). 1988 Aug;36(8):3060-9. doi: 10.1248/cpb.36.3060.

10

[Enhancement of Walker-256 antitumor effect by intra-arterial administration of TNF before using mitomycin C].[在使用丝裂霉素C之前通过动脉内给予肿瘤坏死因子增强Walker-256肿瘤的抗肿瘤作用]

Gan To Kagaku Ryoho. 1988 Aug;15(8 Pt 2):2392-5.

引用本文的文献

1

Liposomes as carriers of cancer chemotherapy. Current status and future prospects.脂质体作为癌症化疗的载体。现状与未来展望。

Drugs. 1993 Oct;46(4):618-38. doi: 10.2165/00003495-199346040-00004.

2

Effect of plasma protein binding on drug disposition in muscle tissue: application of statistical moment analysis and network theory to in situ local single-pass perfusion system.血浆蛋白结合对肌肉组织中药物处置的影响：统计矩分析和网络理论在原位局部单通道灌注系统中的应用

J Pharmacokinet Biopharm. 1988 Apr;16(2):129-49. doi: 10.1007/BF01062256.